This hypothesis proposes that carcinogens in the breast are generated by the action of superoxide free radicals released when acinal gland distension, under the influence of unopposed prolactin, causes microvessel ischaemia. Inadequate nipple care in the at-risk years leads to ductal obstruction preventing the elimination of carcinogens from the breast. The regular production of oxytocin (OT) from nipple stimulation would cause contraction of the myoepithelial cells, relieving acinal gland distension and aiding the active elimination of carcinogenic fluid from the breast.
Mechanical breast pump stimulation causes an increase in plasma OT levels in the luteal but not in the follicular phase of the menstrual cycle. OT production upon nipple stimulation in the luteal phase of premenopausal, non-lactating women may be protective against the high rates of mitotic breast cell division noted at this time via the potential to block the effect of oestrogen.
The epidemiology of breast cancer suggests that lengthy lactation time is beneficial. Sexual activity in nulliparous women also protects and OT levels have been shown to rise with orgasm in women and in men. OT systems in the brain are intricately linked to oestrogen and progesterone levels, and it is possible that these hormones may modify the OT secretory response both centrally and through an effect on the sensitivity of the breast.
OT production with nipple care and in sex and lactation, and the reduction in cycling ovarian hormones that occurs with pregnancy, may all be important preventative factors in the development of breast cancer both pre- and post-menopausally.
This is a preview of subscription content, log in to check access.
Buy single article
Instant access to the full article PDF.
Price includes VAT for USA
Subscribe to journal
Immediate online access to all issues from 2019. Subscription will auto renew annually.
This is the net price. Taxes to be calculated in checkout.
Murrell TGC: Epidemiological and biochemical support for a theory on the cause and prevention of breast cancer. Medical Hypotheses 36: 389–396, 1991
Murrell TGC, Head JE: The potential for oxytocin to prevent breast cancer. Abstract. The challenge of breast cancer: The Lancet Conference, Brugge, Belgium. April 21–22, 1994
Hippocrates: Des maladies des femmes. In Littre (ed) Vol 8 pp 282-283 Paris JB Bailliere, 1839
Hippocrates: The genuine works of Hippocrates. Translated by F. Adams Vol 2 p 748 London, Sydenham Society, 1849
Soranus: Gyneacology. Translated by O Temkin Vol 3 Baltimore, John Hopkins Press, 1956
deMoulin D: A short history of breast cancer. Pp 19-24 Paris JB Bailliere, 1839
Mustacchi P, Ramazzini B, Rigoni-Stern DA: Parity and breast cancer. Arch Int Med 108: 185–198, 1961
Fildes V: Breasts, bottles and babies pp 102–103 Edinburgh, University Press, 1986
Murrell TGC: Loving, living and longevity: maybe sex is good for you. Proceedings Annual Scientific Symposium. Australian Academic Association of General Practice. Perth Western Australia: September, 1990
Murrell TGC: The benefits of sex. Seminar, Department of Psychology, University of Adelaide, South Australia, April 1991
Leake RD, Buster JE, Fisher DA: The oxytocin secretory response to breast stimulation in women during the menstrual cycle. Am J Obstet Gynecol 148: 457–460, 1984
Longacre TA, Barlow SA: A correlative morphologic study of human breast and endometrium in the menstrual cycle. Am J Surg Pathol 10: 382–393, 1986
Carmichael MS, Humbert R, Dixen J, Palmisano G, Greenleaf W, Davidson JM: Plasma oxytocin increases in human sexual response. J Clin Endocrin Metab 64: 27–31, 1987
Konickx P: Stress hyperprolactinemia in clinical practice. Lancet 1: 273–275, 1978
Kolodny RC, Jacobs LS, Daughaday WH: Mammary stimulation causes prolactin secretion in non-lactating women. Nature 238: 284–285, 1972
Jarrell J, Franks S, McInnes R, Gemayel K, Guyda H, Arronet GH, Naftolin F: Breast examination does not elevate serum prolactin. Fertility and Sterility 3: 49–51, 1980
Mogg RJ, Samson WK: Interactions of dopaminergic and peptidergic factors in the control of prolactin release. Endocrinology 126: 728–735, 1990
Bulbrook RD: Geographical variation in endocrine function and its relation to breast cancer incidence: some general considerations. Breast Cancer Research and Treatment 18: 537–540, 1991
Dreifuss JJ, Tribollet E, Dubois-Dauphin M, Raggenbass M: Receptors and neural effects of oxytocin in the rodent hypothalamus and preoptic region. Ciba Found Symp 168: 187–199, 1992
Key TJ, Pike MC: The role of oestrogens and progestagens in the epidemiology and prevention of breast cancer. Eur J Cancer Clin Oncol 24(1): 29–43, 1988
Laatikainen TJ: Corticotrophin releasing hormone and opioid peptides in reproduction and stress. Ann Med 23(5): 489–496, 1991
Murrell GAC, Murrell TGC, Pilowsky E: A hypothesis for the resolution of Dupuytren's contracture with allopurinol. Spec Sci Tech 102: 107–112, 1987
Murrell GAC, Francis MJO, Bromley J: Free radicals and Dupuytren's contraction. Br Med J 295: 1373–1375, 1989
Murrell GAC, Francis MJO, Bromley J: Modulation of fibroblast proliferation by oxygen free radicals. Biochem J 265: 659–665, 1990
Jarasch ED, Grund C, Bruder G, Heid HW, Keenan TW, Frankie WW: Localisation in mammary gland epithelium and capillary endothelium. Cell 25: 67–82, 1981
Slater TF: Free radical mechanisms in tissue injury. Biochem J 222: 1–15, 1984
Slater TF: Free radical mechanisms in tissue injury. In: Cell Function and Disease. Candeo LE, Todd LE, Packer L, Jaz J (eds) pp 209–218 New York, Plenum Publishing Corp, 1989
Petrakis NL, Maack CA, Lee RE, Lyon M: Mutagenic activity in nipple aspirates of human breast fluid. Cancer Research 40: 188–189, 1980
Wainwright JMA: A comparison of conditions associated with breast cancer in Great Britain and America. Amer J Cancer 15: 2610–2645, 1931
Jacobson HJ, Thompson WD, Janerich DT: Multiple births and maternal risk of breast cancer. Amer J Epidemiol 129: 865–873, 1989
Layde PM, Webster LA, Baughman AL, Wingo PA, Rubin GL, Ory HW: The independent associations of parity age at first full term pregnancy, and duration of breast feeding with the risk of breast cancer. Cancer and Steroid Hormone Study Group. J Clin Epidemiol 42: 10: 963–973, 1989
Thomas BT, Noonan EA, WHO Collaborative Study of Neplasia and Steroid Contraceptives. Breast cancer and prolonged lactation. International Journal of Epidemiology 22: 4:619-625
Newcomb PA, Storer BE, Longnecker MP, et al. Lactation and a reduced risk of premenopausal breast cancer. The New England Journal of Medicine. 330: 2: 81-87
Yang CP, Weiss NS, Band PR, Gallagher RP, White E, Daling JR History of lactation and breast cancer risk. American Journal of Epidemiology 138: 12: 1050-1056
McTiernan A, Thomas DB: Evidence for a protective effect of lactation on risk of breast cancer in young women. Results from a case control study. Amer J Epidemiol 124: 353–358, 1986
Ing R, Ho JHC, Petrakis NL: Unilateral breast feeding and breast cancer. Lancet 2: 124–127, 1977
Garland FC, Garland CF, Gorham ED, Young JF: Geographic variation in breast cancer mortality in the United States. Preventive Medicine 19: 614–622, 1990
Monique G, Bachelot A, Hill C: Characteristics of reproductive life and risk of breast cancer in a case-control study of young nulliparous women. J Clin Epidemiol 42: 1227–1233, 1989
Cross BA, Findlay ALR: Comparative and sensory aspects of milk ejection. In: Lactogenesis: the initiation of milk secretion at parturition. Reynolds M, Folley SJ (eds) Philadelphia, Univ. Pennsylvania Press, 1969
About this article
Cite this article
Murrell, T.G.C. The potential for oxytocin (OT) to prevent breast cancer: a hypothesis. Breast Cancer Res Tr 35, 225–229 (1995). https://doi.org/10.1007/BF00668213
- ductal obstruction
- functional breast behaviour
- microvessel ischemia